TFS Trial Form Support   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Lund Sweden (1994)

Organization Overview

First Clinical Trial
2007
NCT00485017
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

TFS Trial Form Support | TFS Trial Form Support International AB

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Amyotrophic Lateral Sclerosis (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Colorectal Neoplasms (Phase 2)

Conjunctivitis (Phase 2)

Conjunctivitis, Viral (Phase 2)

Crohn Disease (Phase 3)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Heart Failure (Phase 3)

Inflammation (Phase 3)

Keratoconjunctivitis (Phase 2)

Macular Degeneration (Phase 4)

Motor Neuron Disease (Phase 3)

Mucositis (Phase 3)

Multiple Myeloma (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Obesity (Phase 2)

Parkinson Disease (Phase 1)

Prostatic Neoplasms (Phase 2)

Psoriasis (Phase 2)

Spondylolisthesis (Phase 2)

Wet Macular Degeneration (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 29
  • # of Trial APIs: 38